Virgil E.J.C. Schijns

2.8k citations

59 papers · 2.0k indexed · h-index 27

Co-authors: Ed C. Lavelle Winfried G.J. Degen Marius Strioga Lisa Rothwell Pete Kaiser Jaroslav Michálek Vita Pašukonienė Huub F. J. Savelkoul
Topics: Immunotherapy and Immune Responses (35 papers)Immune Response and Inflammation (12 papers)vaccines and immunoinformatics approaches (11 papers)
Cited by: Immunology Microbiology Animal Science and Zoology
Journals: The Journal of Immunology PLoS ONE International Journal of Molecular Sciences
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Virgil E.J.C. Schijns

56 papers receiving 2.0k citations

Peers

Countries citing papers authored by Virgil E.J.C. Schijns

Since Specialization

Citations

This map shows the geographic impact of Virgil E.J.C. Schijns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virgil E.J.C. Schijns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virgil E.J.C. Schijns more than expected).

Fields of papers citing papers by Virgil E.J.C. Schijns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virgil E.J.C. Schijns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virgil E.J.C. Schijns. The network helps show where Virgil E.J.C. Schijns may publish in the future.

Co-authorship network of co-authors of Virgil E.J.C. Schijns

This figure shows the co-authorship network connecting the top 25 collaborators of Virgil E.J.C. Schijns. A scholar is included among the top collaborators of Virgil E.J.C. Schijns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virgil E.J.C. Schijns. Virgil E.J.C. Schijns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide 2022 ·Frontiers in Oncology ·Daniela A. Bota,Thomas H. Taylor,Naomi Lomeli,Xiao–Tang Kong,(unknown),Axel H. Schönthal,Samuel Singer,Deborah T. Blumenthal,Frank M. Senecal,Helena Linardou,(unknown),(unknown),Virgil E.J.C. Schijns,Thomas C. Chen,(unknown),(unknown)	5
2	Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma : interim results and correlations with CD4+ T-lymphocyte counts 2018 ·JAMA Oncology ·Daniela A. Bota,(unknown),(unknown),Jose Carrillo,(unknown),(unknown),Frank P. K. Hsu,Axel H. Schönthal,Florence M. Hofman,Thomas C. Chen,Raphael Zidovetzki,(unknown),Ankie Strik,Virgil E.J.C. Schijns,(unknown)	3
3	Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines 2018 ·Vaccine ·(unknown),Vita Pašukonienė,Adas Darinskas,(unknown),(unknown),(unknown),Živilė Gudlevičienė,(unknown),Virgil E.J.C. Schijns,Werner Lubitz,(unknown),Marius Strioga	37
4	Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use? 2014 ·Vaccine ·Marius Strioga,Adas Darinskas,Vita Pašukonienė,(unknown),(unknown),Virgil E.J.C. Schijns	29
5	Dendritic cells and their role in tumor immunosurveillance 2013 ·Journal of Innate Immunity ·Marius Strioga,Virgil E.J.C. Schijns,Daniel J. Powell,Vita Pašukonienė,(unknown),Jaroslav Michálek	30
6	Therapeutic Dendritic Cell-Based Cancer Vaccines: The State of the Art 2013 ·Critical Reviews in Immunology ·Marius Strioga,Thomas Felzmann,Daniel J. Powell,(unknown),(unknown),Miroslava Matúšková,Jaroslav Michálek,Virgil E.J.C. Schijns	32
7	Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation 2012 ·OncoImmunology ·(unknown),(unknown),(unknown),(unknown),Florence M. Hofman,Carol A. Kruse,Martin R. Jadus,Thomas C. Chen,Virgil E.J.C. Schijns	20
8	A Novel Soluble Immune-Type Receptor (SITR) in Teleost Fish: Carp SITR Is Involved in the Nitric Oxide-Mediated Response to a Protozoan Parasite 2011 ·PLoS ONE ·Carla M. S. Ribeiro,Steve Bird,Geert Raes,Gholamreza Hassanzadeh Ghassabeh,Virgil E.J.C. Schijns,(unknown),Huub F. J. Savelkoul,Geert F. Wiegertjes	20
9	Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants 2009 ·Vaccine ·(unknown),(unknown),(unknown),(unknown),Virgil E.J.C. Schijns,Anja R. Heckeroth	20
10	Immunology of Vaccine Adjuvants 2009 ·Methods in molecular biology ·Carla M. S. Ribeiro,Virgil E.J.C. Schijns	23
11	Veterinary vaccine development from an industrial perspective 2008 ·The Veterinary Journal ·J.G.M. Heldens,Jay Patel,N. Chanter,(unknown),(unknown),Virgil E.J.C. Schijns,(unknown),Th.P.M. Schetters	40
12	Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model 2008 ·Vaccine ·Niels Hagenaars,Enrico Mastrobattista,Harrie L. Glansbeek,Jacco Heldens,Han van den Bosch,Virgil E.J.C. Schijns,Didier Betbeder,Herman Vromans,Wim Jiskoot	65
13	Molecular immunophenotyping of lungs and spleens in naive and vaccinated chickens early after pulmonary avian influenza A (H9N2) virus infection 2006 ·Vaccine ·Winfried G.J. Degen,Jacqueline Smith,(unknown),Elizabeth Glass,David W. Burt,Virgil E.J.C. Schijns	26
14	Structure- and oil type-based efficacy of emulsion adjuvants 2006 ·Vaccine ·(unknown),(unknown),(unknown),(unknown),Virgil E.J.C. Schijns	38
15	Characterization of the First Nonmammalian T2 Cytokine Gene Cluster: The Cluster Contains Functional Single-Copy Genes for IL-3, IL-4, IL-13, and GM-CSF, a Gene for IL-5 That Appears to Be a Pseudogene, and a Gene Encoding Another Cytokinelike Transcript, KK34 2004 ·Journal of Interferon & Cytokine Research ·Stuart Avery,Lisa Rothwell,(unknown),Virgil E.J.C. Schijns,John R. Young,Jim Kaufman,Pete Kaiser	119
16	Immunisation with virion-loaded plasmacytoid or myeloid dendritic cells induces primary Th-1 immune responses 2004 ·Vaccine ·(unknown),Marian C. Horzinek,Bart L. Haagmans,Virgil E.J.C. Schijns	3
17	Structure–activity relations of water-in-oil vaccine formulations and induced antigen-specific antibody responses 2004 ·Vaccine ·(unknown),(unknown),(unknown),Virgil E.J.C. Schijns	34
18	Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants 2003 ·Vaccine ·Virgil E.J.C. Schijns	44
19	Antigen delivery systems and immunostimulation 2002 ·Veterinary Immunology and Immunopathology ·Virgil E.J.C. Schijns	14
20	Production of biologically active equine interleukin 12 through expression of p35, p40 and single chain IL‐12 in mammalian and baculovirus expression systems 2001 ·Equine Veterinary Journal ·Elizabeth L. McMonagle,Simon Taylor,(unknown),Laura Sanders,N.C. Scholtes,(unknown),C. A. Hopkins,Nicola Logan,(unknown),D. J. Argyle,David Onions,Virgil E.J.C. Schijns,L. Nicolson	13

About Virgil E.J.C. Schijns

Virgil E.J.C. Schijns is a scholar working on Immunology, Biotechnology and Genetics, having authored 59 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (35 papers), Immune Response and Inflammation (12 papers) and vaccines and immunoinformatics approaches (11 papers). The work is most often cited by research in Immunology (1.1k citations), Microbiology (193 citations) and Animal Science and Zoology (307 citations). Virgil E.J.C. Schijns has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Ed C. Lavelle, Winfried G.J. Degen, Marius Strioga, Lisa Rothwell, Pete Kaiser, Jaroslav Michálek, Vita Pašukonienė, Huub F. J. Savelkoul, Stuart Avery and Jim Kaufman. Their work appears in journals such as The Journal of Immunology, PLoS ONE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact